Sotalol-induced torsades de pointes precipitated during treatment with oseltamivir for H1N1 influenza.

摘要

Novel influenza A (H1N1) is a flu virus of swine origin that first caused human illness in Mexico and the United States in March and April of 2009. By June of 2009, all 50 states had reported cases of novel H1N1 infection. On June 11, 2009, the World Health Organization (WHO) elevated the worldwide pandemic alert to Phase 6, indicating widespread human-to-human transmission and recognition that H1N1 spread had reached pandemic proportions. The WHO has recommended that antiviral agents, including oseltamivir, be used in the treatment of suspected or confirmed cases of H1N1 influenza in at risk patients, such as the very young, elderly, pregnant woman, immunosup-pressed patients, and those with comorbid conditions.